Thomas Jefferson University: Targeting Cell Division in Pancreatic Cancer
August 20, 2019
August 20, 2019
PHILADELPHIA, Pennsylvania, Aug. 20 [TNSmedicalresearch] -- Thomas Jefferson University issued the following news:
* * *
- Study provides new evidence of synergistic effects of drugs that inhibit cell division and support for further clinical trials.
* * *
Pancreatic cancer is one of the deadliest cancers, with patients surviving on average less than a year once the disease has spread. There is an urgent need to evaluate more therapeutic target . . .
* * *
- Study provides new evidence of synergistic effects of drugs that inhibit cell division and support for further clinical trials.
* * *
Pancreatic cancer is one of the deadliest cancers, with patients surviving on average less than a year once the disease has spread. There is an urgent need to evaluate more therapeutic target . . .